More Evidence Poor Cancer Patients Don’t Join Clinical Trials
(Reuters Health) - Low-income cancer patients are much less likely to participate in clinical trials than their more affluent peers, a U.S. study confirms.
Even after accounting for gender, age, race, travel distance from treatment sites and certain diagnosis details, patients with household income of less than $50,000 a year were 32 percent less likely to enroll in trials than those who make more annually, according to the study published Thursday in JAMA Oncology.
The disparity was even more stark for patients with household income below $20,000, who were 75 percent less likely to join cancer studies than the wealthier people in the study.
“Low-income patients are likely more sensitive about how to pay for clinical trial treatment, including direct costs like co-pays and co-insurance, or indirect or hidden costs such as taking time off work for extra clinic visits,” said lead study author Joseph Unger, a biostatistician at the Fred Hutchinson Cancer Research Center in Seattle.
While some previous survey research has suggested household finances might be an important predictor of access to clinical trials, the current study confirms this is happening based on patient-level income data collected before participants decided whether to join cancer trials.
For the current study, researchers analyzed data on 1,262 adults at eight cancer clinics across the U.S. who were diagnosed with breast, lung or colorectal tumors.
Patients joined the study before they made treatment decisions, and were followed for up to six months to see whether or not they opted to participate in a clinical trial.
Most of the participants were women, had at least some college education, lived at least 13 miles away from the treatment center and were younger than 65 years old.
Four out of five participants were being diagnosed with cancer for the first time, and the majority had breast tumors.
Roughly half of them had household incomes of at least $50,000, while another 30 percent had annual incomes of $20,000 to $49,999. About one in five came from households with less than $20,000 a year in income.
One problem with fewer low-income patients joining trials is that this may mean these people are less likely to have access to the newest treatments, including experimental therapies, Unger said by email.
“Patients should have equal access to treatments regardless of their income level,” Unger said.
From a research perspective, lower enrollment among low-income patients might slow down the process of starting trials and make it difficult to be certain the results are meaningful for rich and poor alike, he noted.
While there may be ethical concerns about paying patients to participate in trials, it might make sense in some circumstances to consider waiving any out-of-pocket medical costs not covered by insurance to lessen the financial barriers to participation, Unger added.
Cancer Patients: Quality Of Life Could Improve Through Walking
Cancer patients are usually at low energy and are staying on their beds, preventing any excessive physical activities. However, a new study suggests that patients with advanced cancer should walk at least 30 minutes every other day. During a trial to 42 patients that was divided into two groups, those that were having walking session improved their quality of life.
Cancer Cure Update: This ‘Moonshot’ Initiative To Cure Cancer Is The Latest Trend
Considering that it the World Cancer Awareness month, how important is it for people to have adequate knowledge in terms of fighting one of the long dreaded diseases in the world? Is the so-called ‘moonshot’ initiative the key in solving the problem caused by cancer? Find out what health professionals have to say
More Cancer Patients Are Using Crowdfunding To Pay For Treatment
Cancer patients that use crowdfunding to raise funds for private treatment soaring. There were 2,348 appeals on the website NHS last year compared to 304 in 2015.
The Ultimate Cure For Cancer, Finally Found? What Does Elephants Have To Do With It? Here Are The Details
As the quest to finding the right solution for the “deadly” Cancer, what are the Elephants’ essential roles in this disease? Could they actually be the game changer? What’s the truth behind claims that Elephants hold the key for Cancer? Here’s what experts reveal
DNA In Blood May Tell How Long A Pancreatic Cancer Patient Has Left To Live
Pancreatic cancer is a silent killer. Most patients who have been diagnosed with the disease report no symptoms.
Battling Ovarian Cancer: Fitness Blogger Shares Her Story Of How She Combats The Deadly Disease Through Social Media
Considering the rise of ovarian cancer cases being recorded annually, how can a fitness blogger’s testament be used as an inspiration to others out there who are fighting the same battle? The details, inside
MORE IN ITECHPOST
Best Ergonomic Keyboards for Students in 2020
Regardless of which grade a student is in, the computer is an integral part of every classroom. This makes keyboards one of the most important computer philepherals students need to pay attention to for comfort and good ergonomics.
How Do Personal Emergency Response Systems Work?
Personal emergency response systems, known as PERS for short, are systems that help people to raise the alarm and get immediate help when a medical or personal emergency occurs. They are ideal for older people and anyone with a mobility issue or an injury or illness that can cause falls.
The 9 Most Popular (And Fun) Internet Games of 2019
Are you bored of board games? What are the most popular internet games from this year? These nine are popular for a reason. Check 'em out!
Why your Company Needs a Comprehensive ERP Solution Like Microsoft Dynamics 365 Business Central
Statista predicts that the whole ERP market's revenue will exceed $85 million in 2021. By that time, resource planning systems will be used by both SMEs and large businesses. Moreover, even today, it's pretty difficult to find a firm without at least basic ERP products that help to plan, organize, automate, and improve ongoing processes.